Gilead Sciences
GILD
GILD
1,595 hedge funds and large institutions have $62B invested in Gilead Sciences in 2022 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 738 increasing their positions, 533 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.09% more ownership
Funds ownership: 79.25% → 80.34% (+1.1%)
1% more capital invested
Capital invested by funds: $61.3B → $62B (+$677M)
0% less funds holding
Funds holding: 1,596 → 1,595 (-1)
Holders
1,595
Holding in Top 10
43
Calls
$1.17B
Puts
$764M
Top Buyers
| 1 | +$302M | |
| 2 | +$137M | |
| 3 | +$123M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$114M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$110M |
Top Sellers
| 1 | -$224M | |
| 2 | -$209M | |
| 3 | -$172M | |
| 4 |
Morgan Stanley
New York
|
-$149M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$130M |